Moreover, MM patients with extramedullary disease exhibit higher CXCL9 levels in the bone marrow compared to those without extramedullary disease [56], indicating a possible mechanism for the release of MM cells from the bone marrow. The gene discussed is CXCL9; the disease is Miyoshi myopathy.